Clinical Trial

RESist Against Irritability Superiority Trial

Study acronym: RESIST
Recruiting
View on ClinicalTrials.gov →
Summary
Irritability is defined as developmentally inappropriate proneness to anger. Irritability is a symptom of several mental health conditions in children and adolescents such as attention deficit hyperactivity disorder (ADHD), oppositional defiant disorder (ODD), conduct disorder (CD), depressive disorders, anxiety disorders.Irritability has been associated with poor functional outcomes across the lifespan and was found to be specifically associated with concurrent and longitudinal emotional disorders, suicidality and impaired academic and socio-professional functioning. Children with high irritability also have distinct physiological profiles with hyper-reactivity to stress and perceived threats. Despite the high prevalence and health issues related to irritability, there is little treatment research on this topic. Developing evidence-based non-pharmacological treatment options for children suffering from severe, chronic irritability is therefore a particularly important target for clinical research.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-09-02; most recent amendment 2023-08-09.
Status change: Not Yet Recruiting → Recruiting 2023-08-09
Trial Details
NCT Number NCT05528926
Lead Sponsor University Hospital, Montpellier
Conditions Irritable Mood
Enrollment 270 participants
Start Date 2023-04-25
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2023-08-14